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Pyelocalyceal diverticulum, or a pyelogenic cyst, is a urine-
containing eventration of the upper collecting system,
enclosed within the renal parenchyma, communicating
with the main collecting system via a narrow channel, lined
by nonsecretory transitional cell epithelium and surrounded
by a layer of muscularis mucosae [1,2]. Patients with
pyelocalyceal diverticulum are usually asymptomatic but
may report hematuria or have symptoms of urinary tract
infection, renal colic, pyuria, hypertension, or obstruction
due to calculus formation [3].
CASE PRESENTATION
A previously healthy 46-year-old female came to our hospital
for a health examination. A fluorodeoxyglucose (FDG) F-18
positron emission tomography (PET) whole-body scan was
done on 19 August 2004. The patient fasted for longer than
8 hours before the PET examination. The FDG-PET scan
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was performed using a dedicated PET scanner (Siemens
Ecat Exact HR plus, Knoxville, TN, USA), 1 hour after
intravenous injection of 370 MBq of FDG F-18, and showed
an FDG-avid lesion about 4.1 cm in diameter in the left
renal pelvis with a standard uptake value (SUV) of 10.7. To
accelerate the excretion of the radiotracer from the urinary
system, 20 mg of furosemide was given intravenously. A
delayed 3-hour image focused on the kidneys, and the
lesion was clearly identified, but with a lower SUV of 3.9
(Figure 1). The FDG-avid lesion was thought to be due to
benign processes, such as urine stasis in the renal pelvis
secondary to obstruction or a benign tumor, because the
SUV decreased significantly with time. Urinalysis on 20
August 2004 revealed white blood cells, positive; red blood
cells, 0–1; and bacteria, positive. An abdominal sonogram
on the same day revealed an anechoic area in the left renal
pelvis. Either hydronephrosis or a cyst was considered
(Figure 2). An abdominal computed tomography (CT) scan
was performed for further evaluation and showed a 3.7-cm
lesion over the middle of the left kidney (Figure 3). The
immediate impression was that of a complicated cyst with
calcification. After discussions with the patient, she strongly
favored total nephrectomy because she still feared the
lesion might be malignant. She was admitted with a left
complicated cyst, and a left nephrectomy via laparoscope
was performed on 3 September 2004.
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Pathologic examination
A specimen of  the left  kidney showed calyceal
diverticulum. The renal parenchyma, pelvis, and ureter
revealed nothing remarkable. The cyst was lined by
either single or multiple-layer urothelium, with a
smooth muscular wall. No inflammation was seen in
the cystic wall. The cyst was located in the medullary
area, adjacent to the pelvis. On the basis of the histology
and location of the cyst, calyceal diverticulum was
diagnosed.
Figure 3. An abdominal computed tomography image with contrast
shows a 3.7-cm cystic lesion (arrows) with a slightly irregular wall and
calcification (arrowhead) in the left kidney. No enhancement is noted in
the lesion after contrast medium injection. Complicated cyst should be
considered.
Figure 1. Upper row: Fluorodeoxyglucose F-18 (FDG) positron emission tomography (PET) FDG-PET scanning 1 hour after intravenous
injection of 370 MBq of FDG F-18. The coronary (A), transverse (B) and sagittal sections (C) of the scan show one large area of increased FDG
uptake in the right renal pelvis (arrows). The maximum standard uptake value (SUV) of the lesion is 10.7. Lower row: FDG-PET scanning
3 hours after injection of FDG F-18. The FDG-avid lesion is still demonstrated even after administration of furosemide but with lower intensity
(SUV = 3.9) on the coronary (D), transverse (E), and sagittal sections (F).
Figure 2. Abdominal sonogram reveals an anechoic area in the left
kidney (arrows). Either hydronephrosis or a cyst should be considered.
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DISCUSSION
Pooling of the tracer in the renal calices or pelvis, dilated or
redundant ureters, calyceal diverticulum, or bladder
diverticula could be a confusing finding [4]. Such focal FDG
activity could be mistaken for an upper-pole renal neoplasm
or confused with a primary or metastatic neoplasm of the
pancreatic tail or adrenal gland because of the proximity of
these structures. Hydration and the use of furosemide have
been advocated to facilitate clearance of the urinary tracer
from the intrarenal collecting systems and ureters [5];
however, these methods are not uniformly effective. Thus,
even with these considerations, focal FDG activity in the
expected locations of the renal calices, renal pelvis, or ureters
must be considered nonspecific. To reduce image
reconstruction artifacts from the intense tracer activity
encountered in the bladder, some investigators advocate
catheterization and lavage of the bladder [4–6]. In our case,
we administered furosemide to the patient after 1 hour of
imaging to reduce the effect of urine stasis in the urinary
collecting system; the FDG-avid lesion remained, while
the SUV decreased significantly (from 10.7 at 1 hour, to 3.9
at 3 hours).
Recently, delayed imaging using FDG F-18 has been
reported to be useful in the differentiation between benign
and malignant lesions [7–9]. Most malignant lesions show
higher FDG F-18 uptake on the delayed image than on the
early image, whereas most benign lesions show the opposite.
However, in a study by Dobert et al the value of the dual
time point FDG-PET imaging was reportedly limited in the
evaluation of focal abdominal lesions [10]. In their study,
the SUV increased by 64% and decreased by 36% in the
malignant lesions, with an initial SUV of 2.5 or higher
(n = 11). In benign lesions with an initial SUV of 2.5 or higher
(n = 31), the uptake increased in 17 patients (55%) and
decreased in 14 patients (45%). Therefore, the change in
SUV is suitable as a criterion for differentiating between
benign and malignant lesions. In our case, the SUV of the
left renal lesion clearly decreased on the delayed image.
A benign lesion was the preferable conclusion, but a
malignant tumor with prompt washout of FDG F-18 could
not be ruled out completely.
Increased FDG F-18 uptake by renal cell carcinoma is
usually mild. Detection of malignant renal neoplasms
appears to depend on tumor grade, whereas smaller, low-
grade tumors are most frequently missed [11]. According to
the literature, the detection rate of FDG-PET scan for primary
renal cell carcinoma varied from 32 to 94% [12–13]. It is not
unusual to have false-negative findings as a result of
relatively low FDG uptake, or false-positive studies due to
urine stasis. We conclude that, although it is rare, calyceal
diverticulum should be taken into consideration when
evaluating FDG-avid lesions in the kidneys.
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